{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:05:58Z","timestamp":1773367558404,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"crossref","award":["2022D01A147"],"award-info":[{"award-number":["2022D01A147"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Ili Kazakh Autonomous Prefecture","award":["YZ2022Y020"],"award-info":[{"award-number":["YZ2022Y020"]}]},{"name":"Medical and industrial collaborative innovation research project","award":["SZM2021005"],"award-info":[{"award-number":["SZM2021005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04691-5","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T04:23:10Z","timestamp":1770610990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic insights into radiomic and proteomic changes under \u03b21-blockers treatment in hypertensive heart disease and hypertrophic cardiomyopathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhe","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangbin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"4691_CR1","doi-asserted-by":"crossref","unstructured":"Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, et al. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. 2015;8(12):e003285.","DOI":"10.1161\/CIRCIMAGING.115.003285"},{"issue":"20","key":"4691_CR2","first-page":"1671","volume":"102","author":"JC Rodrigues","year":"2016","unstructured":"Rodrigues JC, Amadu AM, Dastidar AG, Szantho GV, Lyen SM, Godsave C, et al. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes. Heart (British Cardiac Society). 2016;102(20):1671\u20139.","journal-title":"Heart (British Cardiac Society)"},{"issue":"39","key":"4691_CR3","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733\u201379.","journal-title":"Eur Heart J"},{"issue":"23","key":"4691_CR4","doi-asserted-by":"publisher","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","volume":"149","author":"SR Ommen","year":"2024","unstructured":"Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, et al. 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23):e1239\u2013311.","journal-title":"Circulation"},{"issue":"4","key":"4691_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","volume":"79","author":"BJ Maron","year":"2022","unstructured":"Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(4):372\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"4691_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1421013","volume":"11","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Chen Z, Qi C, Xu S, Ren R, Li W, et al. Cardiac magnetic resonance imaging for discrimination of hypertensive heart disease and hypertrophic cardiomyopathy: a systematic review and meta-analysis. Front Cardiovasc Med. 2024;11:1421013.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"4691_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00330-016-4468-2","volume":"27","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues JC, Rohan S, Ghosh Dastidar A, Harries I, Lawton CB, Ratcliffe LE, et al. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness \u2265 15 mm. Eur Radiol. 2017;27(3):1125\u201335.","journal-title":"Eur Radiol"},{"issue":"7","key":"4691_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075087","volume":"13","author":"M Arabadjian","year":"2023","unstructured":"Arabadjian M, Nicolas B, Montgomery S, Pleasure M, Collins M, Reuter M, et al. Clinical course and outcomes in adults with co-occurring hypertrophic cardiomyopathy and hypertension: a scoping review protocol. BMJ Open. 2023;13(7):e075087.","journal-title":"BMJ Open"},{"issue":"7","key":"4691_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4070\/kcj.2025.0214","volume":"55","author":"SR Kim","year":"2025","unstructured":"Kim SR, Kim MN. Revisiting the prognostic landscape of hypertrophic cardiomyopathy and hypertension: the critical role of left ventricular global longitudinal strain. Korean Circ J. 2025;55(7):597\u20139.","journal-title":"Korean Circ J"},{"issue":"6","key":"4691_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.mayocp.2014.01.025","volume":"89","author":"JM Bos","year":"2014","unstructured":"Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc. 2014;89(6):727\u201337.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"4691_CR11","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1002\/ehf2.14988","volume":"11","author":"G Domain","year":"2024","unstructured":"Domain G, Biscond M, Dognin N, Strube C, Mondoly P, R\u00e9ant P, et al. The D-HCM score, a new diagnostic tool for distinguishing hypertrophic cardiomyopathy from hypertensive cardiopathy. ESC Heart Fail. 2024;11(6):3924\u201333.","journal-title":"ESC Heart Fail"},{"issue":"14","key":"4691_CR12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","volume":"33","author":"R Spoladore","year":"2012","unstructured":"Spoladore R, Maron MS, D\u2019Amato R, Camici PG, Olivotto I. Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J. 2012;33(14):1724\u201333.","journal-title":"Eur Heart J"},{"issue":"10","key":"4691_CR13","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1161\/HYPERTENSIONAHA.123.19460","volume":"81","author":"LA Gottlieb","year":"2024","unstructured":"Gottlieb LA, Mahfoud F, Stavrakis S, Jespersen T, Linz D. Autonomic nervous system: a therapeutic target for cardiac end-organ damage in hypertension. Hypertension (Dallas, Tex\u202f: 1979). 2024;81(10):2027\u201337.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"3","key":"4691_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","volume":"9","author":"N Koitabashi","year":"2011","unstructured":"Koitabashi N, Kass DA. Reverse remodeling in heart failure--mechanisms and therapeutic opportunities. Nat Rev Cardiol. 2011;9(3):147\u201357.","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"4691_CR15","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","volume":"275","author":"RE Schmieder","year":"1996","unstructured":"Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996;275(19):1507\u201313.","journal-title":"JAMA"},{"issue":"5","key":"4691_CR16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","volume":"45","author":"K Wachtell","year":"2005","unstructured":"Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahl\u00f6f B, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol. 2005;45(5):712\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4691_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jchf.2018.02.010","volume":"6","author":"JB Geske","year":"2018","unstructured":"Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy: clinical update. JACC Heart Fail. 2018;6(5):364\u201375.","journal-title":"JACC Heart Fail"},{"issue":"25","key":"4691_CR18","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","volume":"78","author":"AM Dybro","year":"2021","unstructured":"Dybro AM, Rasmussen TB, Nielsen RR, Andersen MJ, Jensen MK, Poulsen SH. Randomized trial of Metoprolol in Patients With Obstructive Hypertrophic\u00a0Cardiomyopathy. J Am Coll Cardiol. 2021;78(25):2505\u201317.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4691_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40360-024-00815-w","volume":"25","author":"Y Yan","year":"2024","unstructured":"Yan Y, An W, Mei S, Zhu Q, Li C, Yang L, et al. Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS). BMC Pharmacol Toxicol. 2024;25(1):86.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"47","key":"4691_CR20","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913\u201324.","journal-title":"Eur Heart J"},{"issue":"10","key":"4691_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","volume":"22","author":"WR Reay","year":"2021","unstructured":"Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet. 2021;22(10):658\u201371.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"4691_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007849","volume":"14","author":"YJ Shimada","year":"2021","unstructured":"Shimada YJ, Raita Y, Liang LW, Maurer MS, Hasegawa K, Fifer MA, et al. Comprehensive proteomics profiling reveals circulating biomarkers of hypertrophic cardiomyopathy. Circ Heart Fail. 2021;14(7):e007849.","journal-title":"Circ Heart Fail"},{"key":"4691_CR23","doi-asserted-by":"crossref","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Science translational medicine. 2017;9(383):eaag1166.","DOI":"10.1126\/scitranslmed.aag1166"},{"issue":"6","key":"4691_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012393","volume":"18","author":"CC Topriceanu","year":"2025","unstructured":"Topriceanu CC, Vissing CR, Axelsson Raja A, Day SM, Russell MW, Zahka K, et al. Proteomic analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial. Circ Heart Fail. 2025;18(6):e012393.","journal-title":"Circ Heart Fail"},{"issue":"9","key":"4691_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.123.064974","volume":"149","author":"S Prapiadou","year":"2024","unstructured":"Prapiadou S, \u017divkovi\u0107 L, Thorand B, George MJ, van der Laan SW, Malik R, et al. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis. Circulation. 2024;149(9):669\u201383.","journal-title":"Circulation"},{"key":"4691_CR26","doi-asserted-by":"crossref","unstructured":"Gill D, Georgakis MK, Koskeridis F, Jiang L, Feng Q, Wei WQ, et al. Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects. Circulation. 2019;140(4):270\u20139. Circulation https:\/\/www.ahajournals.org\/action\/downloadSupplement?doi=10.1161%2FCIRCULATIONAHA.118.038814","DOI":"10.1161\/CIRCULATIONAHA.118.038814"},{"key":"4691_CR27","doi-asserted-by":"crossref","unstructured":"Fan B, Zhao JV. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations. BMC medicine. 2024;22(1):6. GTEx https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/instance\/10763027\/bin\/12916_2023_3218_MOESM1_ESM.docx.","DOI":"10.1186\/s12916-023-03218-6"},{"key":"4691_CR28","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318. FinnGen https:\/\/r12.finngen.fi\/."},{"key":"4691_CR29","doi-asserted-by":"crossref","unstructured":"Zhao B, Li T, Fan Z, Yang Y, Shu J, Yang X, et al. Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images. Science (New York, NY). 2023;380(6648):abn6598. Zenodo https:\/\/zenodo.org\/record\/7239166.","DOI":"10.1126\/science.abn6598"},{"key":"4691_CR30","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622(7982):329\u201338. UKBPPP http:\/\/ukb-ppp.gwas.eu."},{"issue":"8","key":"4691_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","volume":"27","author":"EG Brown","year":"2004","unstructured":"Brown EG. Using MedDRA: implications for risk management. Drug Saf. 2004;27(8):591\u2013602.","journal-title":"Drug Saf"},{"issue":"8","key":"4691_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13(8):519\u201323.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"4691_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"4691_CR34","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awad070","volume":"146","author":"J Lin","year":"2023","unstructured":"Lin J, Zhou J, Xu Y. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. Brain. 2023;146(8):3364\u201372.","journal-title":"Brain"},{"issue":"7","key":"4691_CR35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ajhg.2021.05.014","volume":"108","author":"H Xue","year":"2021","unstructured":"Xue H, Shen X, Pan W. Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet. 2021;108(7):1251\u201369.","journal-title":"Am J Hum Genet"},{"issue":"16","key":"4691_CR36","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"key":"4691_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3724\/SP.J.1042.2014.00731","volume":"22","author":"ZL Wen","year":"2014","unstructured":"Wen ZL, Ye B. Analyses of Mediating Effects: The Development of Methods and Models. Advances in Psychological Science. 2014;22:731\u201345.","journal-title":"Advances in Psychological Science"},{"issue":"11","key":"4691_CR38","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","volume":"94","author":"WM Su","year":"2023","unstructured":"Su WM, Gu XJ, Dou M, Duan QQ, Jiang Z, Yin KF, et al. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2023;94(11):954\u201361.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"4691_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101174","volume":"4","author":"S Yuan","year":"2023","unstructured":"Yuan S, Xu F, Li X, Chen J, Zheng J, Mantzoros CS, et al. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses. Cell reports Medicine. 2023;4(9):101174.","journal-title":"Cell reports Medicine"},{"issue":"5","key":"4691_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481\u20137.","journal-title":"Nat Genet"},{"key":"4691_CR41","doi-asserted-by":"crossref","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nature genetics. 2021;53(12):1712\u201321. deCODE https:\/\/www.decode.com\/summarydata.","DOI":"10.1038\/s41588-021-00978-w"},{"key":"4691_CR42","doi-asserted-by":"crossref","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, W\u00f6rheide MA, et al. Mapping the proteo-genomic convergence of human diseases. Science (New York, NY). 2021;374(6569):eabj1541. Fenland https:\/\/studies.mrc-epid.cam.ac.uk\/fenland\/researchers.","DOI":"10.1126\/science.abj1541"},{"key":"4691_CR43","doi-asserted-by":"crossref","unstructured":"Gudjonsson A, Gudmundsdottir V, Axelsson GT, Gudmundsson EF, Jonsson BG, Launer LJ, et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nature communications. 2022;13(1):480. Gudjonsson https:\/\/www.ebi.ac.uk\/gwas\/home.","DOI":"10.1038\/s41467-021-27850-z"},{"key":"4691_CR44","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nature genetics. 2021;53(9):1300\u201310. eQTLGen https:\/\/www.eqtlgen.org\/cis-eqtls.html."},{"key":"4691_CR45","doi-asserted-by":"crossref","unstructured":"McRae AF, Marioni RE, Shah S, Yang J, Powell JE, Harris SE, et al. Identification of 55,000 Replicated DNA Methylation QTL. Scientific reports. 2018;8(1):17605. McRae https:\/\/yanglab.westlake.edu.cn\/software\/smr\/#mQTLsummarydata.","DOI":"10.1038\/s41598-018-35871-w"},{"issue":"5","key":"4691_CR46","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.123.22504","volume":"81","author":"Y Hu","year":"2024","unstructured":"Hu Y, Lin L, Zhang L, Li Y, Cui X, Lu M, et al. Identification of circulating plasma proteins as a mediator of hypertension-driven cardiac remodeling: a mediation Mendelian randomization study. Hypertension. 2024;81(5):1132\u201344.","journal-title":"Hypertension"},{"issue":"1","key":"4691_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jjcc.2011.08.003","volume":"59","author":"K Nishimura","year":"2012","unstructured":"Nishimura K, Okayama H, Inoue K, Saito M, Yoshii T, Hiasa G, et al. Direct measurement of radial strain in the inner-half layer of the left ventricular wall in hypertensive patients. J Cardiol. 2012;59(1):64\u201371.","journal-title":"J Cardiol"},{"issue":"10","key":"4691_CR48","first-page":"1352","volume":"24","author":"H Elghazaly","year":"2023","unstructured":"Elghazaly H, McCracken C, Szabo L, Malcolmson J, Manisty CH, Davies AH, et al. Characterizing the hypertensive cardiovascular phenotype in the UK Biobank. Eur Heart J. 2023;24(10):1352\u201360.","journal-title":"Eur Heart J"},{"issue":"4","key":"4691_CR49","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jmri.28580","volume":"58","author":"LC Kong","year":"2023","unstructured":"Kong LC, Wu LM, Wang Z, Liu C, He B. An integrated algorithm for differentiating hypertrophic cardiomyopathy from hypertensive heart disease. J Magn Reson Imaging. 2023;58(4):1084\u201397.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"4691_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.21037\/cdt-23-350","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Tian J, Zhang C, Wang H, Hui K, Wang T, et al. Discrimination models with radiomics features derived from cardiovascular magnetic resonance images for distinguishing hypertensive heart disease from hypertrophic cardiomyopathy. Cardiovascular diagnosis and therapy. 2024;14(1):129\u201342.","journal-title":"Cardiovascular diagnosis and therapy"},{"issue":"5","key":"4691_CR51","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jmri.25681","volume":"46","author":"HY Xu","year":"2017","unstructured":"Xu HY, Chen J, Yang ZG, Li R, Shi K, Zhang Q, et al. Early marker of regional left ventricular deformation in patients with hypertrophic cardiomyopathy evaluated by MRI tissue tracking: the effects of myocardial hypertrophy and fibrosis. J Magn Reson Imaging. 2017;46(5):1368\u201376.","journal-title":"J Magn Reson Imaging"},{"key":"4691_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijcard.2018.07.057","volume":"274","author":"SS Khan","year":"2019","unstructured":"Khan SS, Kim KA, Peng J, Aguilar FG, Selvaraj S, Martinez EE, et al. Clinical correlates and heritability of cardiac mechanics: The HyperGEN study. Int J Cardiol. 2019;274:208\u201313.","journal-title":"Int J Cardiol"},{"issue":"3","key":"4691_CR53","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jtha.2023.11.013","volume":"22","author":"S Yuan","year":"2024","unstructured":"Yuan S, Xu F, Zhang H, Chen J, Ruan X, Li Y, et al. Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities. J Thromb Haemost. 2024;22(3):738\u201348.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4691_CR54","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/dom.16087","volume":"27","author":"J Geng","year":"2025","unstructured":"Geng J, Ruan X, Wu X, Chen X, Fu T, Gill D, et al. Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease. Diabetes Obes Metab. 2025;27(2):866\u201375.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"4691_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.HYP.12.3.223","volume":"12","author":"JH Laragh","year":"1988","unstructured":"Laragh JH, Lamport B, Sealey J, Alderman MH. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension (Dallas, Tex\u202f: 1979). 1988;12(3):223\u20136.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"17","key":"4691_CR56","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1161\/01.CIR.101.17.2118","volume":"101","author":"RS Vasan","year":"2000","unstructured":"Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101(17):2118\u201321.","journal-title":"Circulation"},{"issue":"8","key":"4691_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.rec.2024.02.022","volume":"77","author":"F Dom\u00ednguez","year":"2024","unstructured":"Dom\u00ednguez F, Uribarri A, Larra\u00f1aga-Moreira JM, Ruiz-Guerrero L, Pastor-Pueyo P, Gay\u00e1n-Ord\u00e1s J, et al. Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). 2024;77(8):667\u201379.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"4691_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/548783","volume":"2014","author":"MA Ulleryd","year":"2014","unstructured":"Ulleryd MA, Bernberg E, Yang LJ, Bergstr\u00f6m GM, Johansson ME. Metoprolol reduces proinflammatory cytokines and atherosclerosis in ApoE-\/- mice. Biomed Res Int. 2014;2014:548783.","journal-title":"Biomed Res Int"},{"issue":"6","key":"4691_CR59","first-page":"745","volume":"64","author":"G Pyka-Fosciak","year":"2013","unstructured":"Pyka-Fosciak G, Jawien J, Gajda M, Jasek E, Litwin JA. Effect of nebivolol treatment on atherosclerotic plaque components in apoE-knockout mice. Journal of physiology and pharmacology\u202f: an official journal of the Polish Physiological Society. 2013;64(6):745\u201350.","journal-title":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society"},{"issue":"16","key":"4691_CR60","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1111\/jcmm.17869","volume":"27","author":"L Bai","year":"2023","unstructured":"Bai L, Han X, Kee HJ, He X, Kim SH, Jeon MJ, et al. Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase. J Cell Mol Med. 2023;27(16):2290\u2013307.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"4691_CR61","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/cvr\/cvaa266","volume":"117","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wang Y, West TM, Liu Y, Reddy GR, Barbagallo F, et al. Carvedilol induces biased \u03b21 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility. Cardiovasc Res. 2021;117(10):2237\u201351.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"4691_CR62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/hr.2010.242","volume":"34","author":"Y Ti","year":"2011","unstructured":"Ti Y, Hao MX, Li CB, Wang ZH, Hou XY, Zhao XQ, et al. Rosiglitazone attenuates myocardial remodeling in spontaneously hypertensive rats. Hypertension research\u202f: official journal of the Japanese Society of Hypertension. 2011;34(3):354\u201360.","journal-title":"Hypertension research : official journal of the Japanese Society of Hypertension"},{"key":"4691_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.683156","volume":"12","author":"X Cao","year":"2021","unstructured":"Cao X, Mao M, Diao J, Hou Y, Su H, Gan Y, et al. Ectopic Overexpression of PPAR\u03b32 in the Heart Determines Differences in Hypertrophic Cardiomyopathy After Treatment With Different Thiazolidinediones in a Mouse Model of Diabetes. Front Pharmacol. 2021;12:683156.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4691_CR64","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.amepre.2020.10.025","volume":"60","author":"RV Luepker","year":"2021","unstructured":"Luepker RV, Oldenburg NC, Misialek JR, Van\u2019t Hof JR, Finnegan JR, Eder M, et al. Aspirin Use and Misuse for the Primary Prevention of Cardiovascular Diseases. Am J Prev Med. 2021;60(4):513\u20139.","journal-title":"Am J Prev Med"},{"issue":"44","key":"4691_CR65","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1093\/eurheartj\/ehx525","volume":"38","author":"RE Schmieder","year":"2017","unstructured":"Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, et al. The effect of sacubitril\/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. Eur Heart J. 2017;38(44):3308\u201317.","journal-title":"Eur Heart J"},{"issue":"1","key":"4691_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00395-005-0567-y","volume":"101","author":"C Montessuit","year":"2006","unstructured":"Montessuit C, Papageorgiou I, Campos L, Lerch R. Retinoic acids increase expression of GLUT4 in dedifferentiated and hypertrophied cardiac myocytes. Basic Res Cardiol. 2006;101(1):27\u201335.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"4691_CR67","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.122.19459","volume":"80","author":"M Gawa\u0142ko","year":"2023","unstructured":"Gawa\u0142ko M, Linz D. Atrial fibrillation detection and management in hypertension. Hypertension (Dallas, Tex\u202f: 1979). 2023;80(3):523\u201333.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"4691_CR68","doi-asserted-by":"crossref","unstructured":"Finocchiaro G, Magavern E, Sinagra G, Ashley E, Papadakis M, Tome-Esteban M, et al. Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2017;6(12):e007161.","DOI":"10.1161\/JAHA.117.007161"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04691-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:06:14Z","timestamp":1773324374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04691-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4691"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04691-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used only published summary data that does not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}